Renal Cell Cancer

Renal Cell Cancer, often abbreviated as RCC, is the most common type of kidney cancer, originating in the lining of the small tubes in the kidney. Understanding this condition is crucial for early detection and effective management.

Renal Cell Cancer

Key Takeaways

  • Renal Cell Cancer (RCC) is the most prevalent form of kidney cancer, typically starting in the kidney’s filtering tubules.
  • Common renal cell carcinoma symptoms can include blood in the urine, a mass in the abdomen, and persistent flank pain, though often symptoms appear late.
  • While the exact causes of renal cell cancer are unknown, significant risk factors include smoking, obesity, and high blood pressure.
  • Renal cell cancer treatment info highlights surgery as the primary approach, often complemented by targeted therapy, immunotherapy, or radiation, depending on the cancer stage.
  • Early diagnosis significantly improves prognosis, emphasizing the importance of recognizing potential symptoms and risk factors.

What is Renal Cell Cancer (RCC)?

Renal Cell Cancer (RCC) refers to a type of cancer that begins in the cells of the kidneys. Specifically, it typically originates in the lining of the very small tubes in the kidney that filter waste from the blood and make urine. It accounts for approximately 90% of all kidney cancers, making it the most common form. According to the American Cancer Society, kidney cancer is among the top 10 most common cancers in both men and women, with an estimated 81,800 new cases diagnosed in the United States in 2023. This malignancy can occur in one or both kidneys, though it is more commonly found in a single kidney.

The most common subtype of RCC is clear cell renal cell carcinoma, which accounts for about 75% of cases. Other less common types include papillary renal cell carcinoma and chromophobe renal cell carcinoma. The specific type of RCC can influence its growth pattern, prognosis, and response to various treatments, making accurate diagnosis essential for personalized care.

Renal Cell Carcinoma Symptoms and Risk Factors

The presence of renal cell carcinoma symptoms often indicates the cancer has reached an advanced stage, as early-stage RCC typically presents with no noticeable signs. When symptoms do appear, they can be varied and may include blood in the urine (hematuria), a lump or mass in the abdomen or flank, and persistent pain in the side or back. Other general symptoms might include unexplained weight loss, fatigue, fever that is not due to an infection, and swelling in the ankles or legs. It is important to note that these symptoms can also be indicative of other, less serious conditions, necessitating a medical evaluation for proper diagnosis.

While the exact causes of renal cell cancer are not fully understood, several risk factors have been identified that increase an individual’s likelihood of developing the disease. These factors contribute to cellular changes in the kidneys that can lead to cancerous growth.

  • Smoking: Tobacco use significantly increases the risk of RCC.
  • Obesity: Being overweight or obese is a known risk factor.
  • High Blood Pressure (Hypertension): Chronic high blood pressure can elevate the risk.
  • Certain Genetic Syndromes: Conditions like von Hippel-Lindau disease, Birt-Hogg-Dubé syndrome, and hereditary papillary renal cell carcinoma are linked to an increased risk.
  • Long-term Dialysis: Individuals undergoing long-term dialysis for kidney failure have a higher risk.
  • Exposure to Certain Substances: Some studies suggest exposure to certain chemicals, such as cadmium, may increase risk.

Renal Cell Cancer Treatment Options

Accessing comprehensive renal cell cancer treatment info is vital for patients and their families to make informed decisions about care. Treatment strategies for RCC depend on several factors, including the stage and grade of the cancer, the patient’s overall health, and whether the cancer has spread to other parts of the body. Surgery is often the primary treatment for localized RCC, aiming to remove the tumor while preserving as much healthy kidney tissue as possible.

Different surgical approaches are available:

  • Radical Nephrectomy: This involves removing the entire kidney, along with the adrenal gland and surrounding lymph nodes.
  • Partial Nephrectomy: Also known as kidney-sparing surgery, this procedure removes only the tumor and a small margin of healthy tissue, preserving the rest of the kidney. This is often preferred for smaller tumors or when the patient has only one kidney.

Beyond surgery, other treatments play a crucial role, especially for advanced or metastatic RCC. Targeted therapy uses drugs that specifically block the growth and spread of cancer cells by interfering with specific molecules involved in tumor growth. Immunotherapy, on the other hand, boosts the body’s own immune system to fight cancer cells. Radiation therapy may be used to manage symptoms or treat cancer that has spread to other areas, such as bones or the brain. Chemotherapy is generally less effective for RCC compared to other cancers, but it may be considered in specific circumstances. Clinical trials also offer access to new and experimental treatments that may provide additional options for patients.

[EN] Cancer Types

Cancer Clinical Trial Options

Specialized matching specifically for oncology clinical trials and cancer care research.

Your Birthday


By filling out this form, you’re consenting only to release your medical records. You’re not agreeing to participate in clinical trials yet.